cbdMD Inc. announced its financial results for the second quarter of fiscal year 2025, reporting continued growth and a trend towards profitability. The company delivered $4.8 million in revenue, up from $4.3 million in the same period of the previous year. Net sales totaled $4.7 million in the second quarter, representing an 8.6% increase compared to $4.4 million in fiscal 2024. The gross margin rose from 59% to 62% year-over-year. cbdMD's operating loss decreased significantly from $1.5 million to $0.48 million, attributed to disciplined expense management and early traction from new growth initiatives. The net loss before preferred dividends was $0.5 million, a substantial improvement from the $3.0 million loss reported in the prior year period. The company's non-GAAP adjusted EBITDA loss from operations was approximately $197,000, down from about $678,000 in fiscal 2024. Significant business updates include the successful completion of a capital structure reset with the Series A Preferred conversion on May 7, 2025, which eliminated $6.7 million in accrued dividend liability and added equivalent equity value. cbdMD's Herbal Oasis beverage line gained momentum, expanding distribution into Alabama, Florida, and North Carolina, and winning medals at the 2025 High Spirits Awards.